Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HIMSS 2023
  • Opinion
    • Breaking Bias
    • Commentaries
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • 40 Under 40
    • Best Places to Work in Healthcare
    • Healthcare Marketing Impact Awards
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women Leaders
    • Digital Health Transformation Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Looking Ahead to 2024
    • - AI and Digital Health
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Government
April 22, 2016 12:00 AM

Supreme Court patent case has major implications for drugmakers

Lisa Schencker
  • Tweet
  • Share
  • Share
  • Email
  • More

    The pharmaceutical industry is closely watching a case that went before the U.S. Supreme Court on Monday over who should potentially have the upper hand in many patent battles between generic and brand-name drug makers.

    The case, Cuozzo Speed Technologies v. Lee comes as scrutiny over drug prices builds.

    The industry group Pharmaceutical Research and Manufacturers of America wants the justices to reverse a lower court's decision that it says could make it more difficult for them to invest in developing new drugs.

    Meanwhile, the Generic Pharmaceutical Association and insurance industry group America's Health Insurance Plans say the lower court ruling helps ensure more lower-priced generics will be available to consumers.

    The case isn't actually over drugs—it's about an invention that alerts drivers when they're speeding. But it has major implications for many patent disputes in general.

    In 2011, Congress created a system for resolving challenges over the validity of patents, meant as an alternative to engaging in costly and lengthy fights in federal court. Under this new system, such challenges can now be brought to the U.S. Patent and Trademark Office's Patent Trial and Appeal Board. The board, however, has been using a broader standard than federal courts when it comes to interpreting patent claims, making it easier for challengers to invalidate them, many argue.

    PhRMA and others say the board should use the same narrower standard as the federal courts.

    In a brief (PDF) filed in the case, PhRMA said the broader standard creates uncertainty for manufacturers.

    “Uncertainty regarding the scope of patent claims and their validity is costly to the inventive community and discourages innovation,” PhRMA wrote in its brief.

    PhRMA says in cases before the patent board that used the broader standard, 87% of final decisions found at least some claims unpatentable. In federal court, where the narrower standard is used, those challenging patents' validity won 42% of the time.

    AHIP and the generics association, however, said in their brief (PDF) that the broader standard is “largely working as intended by providing a more cost-effective avenue to challenge weak patents.”

    It calls the current process “a critical consumer protection against abusive patent extensions that limit patient access to more affordable treatment options, delay market entry of less expensive generic therapies, and drive up drug costs.”

    They say that without the current process, healthcare costs would rise by at least $73 billion between 2018 and 2037, as calculated by the Center for Economic and Policy Research.

    Generic drug company Mylan Pharmaceuticals also filed a brief in the case supporting the current process, using the broader standard.

    Janelle Waack, a member at Bass Berry & Sims who represents pharmaceutical companies, said if the Supreme Court adopts the narrower standard, challenging patents before the Patent Trial and Appeal Board will become more difficult.

    “It would tend to tilt the playing field in favor of the patent owners,” Waack said.

    It could create a higher barrier for generics trying to get to market, she said.

    “It's remarkable because you're changing the standard of a fundamental issue in anti-patent disputes,” Waack said of the case.

    The Supreme Court heard oral arguments in the case Monday, and a decision is likely by June.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    congress prescription drugs
    PBMs, Big Pharma face off in House hearing
    Most Popular
    1
    Executives detail UnitedHealthcare, Optum Health's growth plans
    2
    Meet the 2023 Most Influential People in Healthcare
    3
    Staff shortages hit Medicare Advantage stars, Kaiser exec says
    4
    Layoffs, benefit cuts follow Medicare Advantage pay reductions
    5
    Trump attack on ACA elevates healthcare in 2024 election
    Sponsored Content
    Modern Healthcare Alert: Sign up for this breaking news email to be kept in the loop as urgent healthcare business news unfolds.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HIMSS 2023
    • Opinion
      • Breaking Bias
      • Commentaries
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • 40 Under 40
        • Best Places to Work in Healthcare
        • Healthcare Marketing Impact Awards
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women Leaders
      • Conferences
        • Digital Health Transformation Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Looking Ahead to 2024
        • - AI and Digital Health
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing